New study tests exercise rehab for melanoma surgery recovery
NCT ID NCT07320222
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether a personalized exercise and education program, given before and after surgery, can help melanoma patients regain strength and function. Thirty adults with melanoma who are scheduled for surgery after chemotherapy will take part. The main goal is to see if such a program is feasible and acceptable to patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- rehabilitation program (exercise education, physiotherapy, tailored exercise plan)
- What this could lead to
- If it works, this could point toward a standard rehab program that helps melanoma patients recover faster and stronger after surgery.
- What could go wrong
- This is a very small pilot study (30 people) testing feasibility, not effectiveness. It may not show clear benefits or be too early to guide treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1
The first testing in people. Mainly checks safety and dose, usually in a small group.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Nov 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * melanoma diagnosis * English speaking, * adults (\>18 years of age) * scheduled to receive surgery after a neoadjuvant chemotherapy regime Exclusion Criteria: * \<18 years of age * are not undergoing neo-adjuvant chemotherapy * self-report any chronic condition, cognitive impairment, or injury that would prevent them from participating independently in moderate intensity exercise
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Melanoma (skin cancer) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your gut bacteria may hold the key to whether immunotherapy works
- Can a DNA vaccine teach the immune system to hunt melanoma?
- Can protein patterns in stored tumors point to new treatment targets?
- Can a new PET tracer light up hidden cancers?
- Can a short Pre-Surgery immunotherapy course replace Long-Term adjuvant treatment for melanoma?
- Which High-Tech camera is better at spotting skin cancer?